CC
Casdin Capital
Venture Capital · Founded 2012 · New York City, United States
Casdin Capital’s biggest current holdings.
The most valuable companies Casdin Capital still holds — unicorns and thoroughbreds it has backed, ordered by Dealroom’s latest valuation. Companies that have been acquired or gone public are in Exits instead. Where a cap table names Casdin Capital directly, the stake and its estimated value are shown too.
-
1
Lyra Health
—
$5.8B
—
-
2
Treeline Biosciences
—
$2.1B
—
-
3
Insitro
—
$1.6B
—
-
4
Formation Bio
—
$1.5B
—
-
5
Kallyope
—
$1.2B
—
-
6
Umoja Biopharma
—
$1.1B
—
-
7
LetsGetChecked
10.5%
$1.0B
$105M
-
8
Thyme Care
—
$1.0B
—
-
9
Komodo Health
—
$800M
—
Estimated value = Casdin Capital’s disclosed ownership % × Dealroom’s latest company valuation; direct named stakes only, exited positions excluded. Figures are indicative, not reported marks. Casdin Capital also appears inside investor groups in Lyra Health, where a standalone stake isn’t disclosed. See the underlying cap tables on Dealroom →
Casdin Capital’s biggest exits.
Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from Casdin Capital’s transaction record.
Where Casdin Capital’s portfolio is concentrated.
Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 138 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.
-
USA130
-
France5
-
Canada4
-
China3
-
UK3
-
Netherlands2
-
Switzerland2
-
South Korea1
-
Health143
-
Enterprise Software4
-
Security2
-
Chemicals1
-
Education1
-
Engineering and Manufacturing Equipment1
-
Fashion1
-
Fintech1
-
Food1
-
Media1
-
Robotics1
-
Transportation1
-
Series B+79
-
Series A48
-
Seed6
-
Late Growth112
-
Breakout Stage25
-
Early Growth12
-
Mature1
Inside Casdin Capital’s portfolio.
The 60 highest-funded portfolio companies, of 138 tracked.
EQ
ClTr
23
SoPa
BrLy
Ex
MaIn
CeLe
Re
Se
Re
AvFoKoKa
Ne
En
Sc
Co
He
Vi
Ve
Th
VeUm
Ge
Ta
A2
Pr
DN
So
Le
Ed
Li
Or
Na
OR
Ad
Fl
Ve
Am
Ta
Kr
Or
Ni
Gr
Ch
Ge
Se
Te
ID
Pa
Mo
CiThWhere Casdin Capital’s portfolio founders come from.
197 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.
-
United States159
-
United Kingdom9
-
France4
-
Netherlands4
-
South Korea4
-
Germany2
-
Ireland1
-
Israel1
-
Massachusetts Institute of Technology12
-
Stanford University11
-
Harvard University10
-
Harvard Medical School8
-
Harvard Business School5
-
University of California, Berkeley5
-
University of Cambridge5
-
Brown University4
-
Columbia University3
-
Leiden University3
-
Dana-Farber Cancer Institute6
-
Harvard University5
-
Massachusetts General Hospital5
-
Broad Institute4
-
McKinsey & Company4
-
Merck & Co.4
-
Stanford University4
-
Stanford University School of Medicine4
-
Third Rock Ventures4
-
Biogen3
Similar investors.
Peers the API surfaces as most similar by portfolio shape, with Dealroom investor rank and portfolio scale.
